Table 1 |
||
|
The clinical and pathological characteristics of 42 cases of prostate cancer and prostate hyperplasia |
||
|
group |
clinical and pathological characteristics |
|
|
|
||
|
Mean age (range) |
Prostate cancer |
68.40 ± 9.55 (57–85) |
|
prostate hyperplasia |
64.18 ± 11.74 (45–81) |
|
|
Histologic examination |
Prostate cancer |
adenocarcinoma |
|
prostate hyperplasia |
Fibromuscuadenomaoid node, adenomaoid node, leiomyomaoid node and fibrohemangioid |
|
|
Pathological evaluation |
Prostate cancer |
Gleason grade IV 10(45.5%) and Gleason grade V 12(54.5%) |
|
prostate hyperplasia |
Moderate hyperplasia 12(60%) and severe hyperplasia 8(40%) |
|
|
Volume(cm3) |
Prostate cancer |
78.53 ± 29.75 |
|
prostate hyperplasia |
45.25 ± 18.97 |
|
|
Local invasion and metastasis |
Prostate cancer |
Local invasion 14(63.4) and metastasis 2(9%) |
|
prostate hyperplasia |
no |
|
|
Level of prostate specific antigen in blood(ng/ml) |
Prostate cancer |
68.57 ± 50.43 |
|
prostate hyperplasia |
20.21 ± 3.27 |
|
|
|
||
|
Zhang et al. Journal of Experimental & Clinical Cancer Research 2008 27:62 doi:10.1186/1756-9966-27-62 |
||
